|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1996-8-22
|
|
pubmed:abstractText |
Bone marrow is the primary site for many hematologic disorders. To date, however, no suitable bone marrow imaging method has been found. The present study investigates the usefulness of bone marrow immunoscintigraphy using 99mTc-labeled antigranulocyte antibody (anti-NCA-95) in 31 patients with hematologic disorders.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
978-82
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8683326-Adolescent,
pubmed-meshheading:8683326-Adult,
pubmed-meshheading:8683326-Aged,
pubmed-meshheading:8683326-Anemia, Aplastic,
pubmed-meshheading:8683326-Antibodies, Monoclonal,
pubmed-meshheading:8683326-Bone Marrow,
pubmed-meshheading:8683326-Female,
pubmed-meshheading:8683326-Granulocytes,
pubmed-meshheading:8683326-Hematologic Diseases,
pubmed-meshheading:8683326-Humans,
pubmed-meshheading:8683326-Leukemia,
pubmed-meshheading:8683326-Male,
pubmed-meshheading:8683326-Middle Aged,
pubmed-meshheading:8683326-Myelodysplastic Syndromes,
pubmed-meshheading:8683326-Radioimmunodetection,
pubmed-meshheading:8683326-Technetium
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Seoul National University Hospital, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
